Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Solarant Medical Inc.

Division of Endo International PLC

Latest From Solarant Medical Inc.

Emerging Competitors in the SUI Market

The sheer size of the stress urinary incontinence market and the potential for future growth have attracted the attention of a number of emerging companies. Although investor interest has waxed and waned over the years, it appears to be heating up once again. This renewed interest is being driven in part by the push to develop efffective nonsurgical treatments that will appeal to an increasingly health-savvy patient population.
Medical Device

NDO Surgical Inc.

NDO Surgical Inc.'s Endoscopic Full-Thickness Plicator, a noninvasive device designed to relieve the symptoms of gastroesophageal reflux disease in an outpatient setting, just received FDA clearance and is poised to enter the billion dollar GERD market.
Medical Device

The Process of Elimination

Incontinence represents a significant unmet medical need for 20 million Americans that suffer from urge incontinence, and 13 million sufferers of stress incontinence. The market is large, growing, and approachable for small device companies--if they can get funding, that is.
BioPharmaceutical Medical Device

Surx Inc.

Dissatisfied with current invasive and complicated surgical techniques for stress urinary incontinence (SUI), the founders of [Surx Inc.] believe they can offer a better approach with a minimally invasive outpatient procedure that uses low power radio frequency (RF) to shrink collagen on the pelvic floor, and return stretched tissues to their normal anatomical position. SUI affects some 6.5 million women in the US, and more than 18 million worldwide
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • SURx Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Endo International PLC
  • Senior Management
  • Garry Carter, Pres.
    Edward Luttich, VP, R&D
  • Contact Info
  • Solarant Medical Inc.
    Phone: (925) 398-4500
    2675 Collier Canyon Rd.
    Livermore, CA 94566
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register